Literature DB >> 2165096

Divergent activities of protein kinases in IL-6-induced differentiation of a human B cell line.

H Goldstein1, D Koerholz, L Chesky, X D Fan, J L Ambrus.   

Abstract

Lymphokines including IL-2, IL-4, and IL-6 are involved in the induction of Ig production by activated B cells. We have investigated the role of protein kinases in IL-6-induced IgM secretion by SKW6.4 cells, an IL-6 responsive B cell line. IL-6-stimulated IgM production was inhibited by elevated intracellular cAMP induced either by the addition of dibutyryl cAMP or cholera toxin. The inhibitory effect of elevated intracellular cAMP was blocked by n-(2-(Methylamino)ethyl)-5-isoquinolinesulfonic dihydrochloride (H8), an inhibitor of protein kinase A. H8 did not affect IgM secretion induced by IL-6. In contrast, the addition of 1-(5-isoquinolinesulfonyl)-2-methylpiperizine dihydrochloride (H7), an inhibitor of protein kinase C activity, markedly inhibited IL-6-stimulated IgM production by SKW6.4 cells. H7 and elevated intracellular cAMP inhibited IgM mRNA expression and subsequent IgM synthesis by SKW6.4 cells. SKW6.4 proliferation, as determined by [3H]thymidine incorporation, was not markedly affected by IL-6, dibutyryl cAMP, cholera toxin, H7 or H8. PMA, an activator of protein kinase C, directly stimulated significant IgM secretion by SKW6.4 cells. When added to PMA-stimulated SKW6.4 cells, IL-6 stimulated additional IgM production. This observation suggested that IL-6 could stimulate differentiation without activating protein kinase C. This was confirmed by demonstrating that IL-6 did not stimulate production of diacylglycerol, did not induce the translocation of protein kinase C from the cytosolic compartment to the plasma membrane and could induce SKW6.4 cells to produce IgM after depletion of their cellular protein kinase C by PMA. Taken together these results suggests that IL-6-stimulated IgM production requires utilization of an H7-inhibitable protein kinase that can be inhibited by a protein kinase A-dependent pathway. Despite the fact that PMA can stimulate IgM production in SKW6.4 cells, IL-6 appears to use a protein kinase pathway other than protein kinase C to induce IgM production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165096

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

2.  Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line.

Authors:  M Faris; N Kokot; N Stahl; A E Nel
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

3.  Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.

Authors:  K Tamura; J Woo; M T Bakri; A W Thomson
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

Review 4.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

5.  Differential effects of interleukin-2 and interleukin-4 on immunomodulatory role of platelet-activating factor in human B cells.

Authors:  C L Patke; C G Green; W T Shearer
Journal:  Clin Diagn Lab Immunol       Date:  1994-07

6.  The concurrent maturation of mouse and human thymocytes in human fetal thymus implanted in NIH-beige-nude-xid mice is associated with the reconstitution of the murine immune system.

Authors:  T R Kollmann; M M Goldstein; H Goldstein
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

7.  Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.

Authors:  Rentian Feng; Christine A Milcarek; Xiang-Qun Xie
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-09       Impact factor: 2.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.